These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 29630971)

  • 1. Effect of altered solution conditions on tau conformational dynamics: Plausible implication on order propensity and aggregation.
    Jebarupa B; Muralidharan M; Srinivasu BY; Mandal AK; Mitra G
    Biochim Biophys Acta Proteins Proteom; 2018; 1866(5-6):668-679. PubMed ID: 29630971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conformational heterogeneity of tau: Implication on intrinsic disorder, acid stability and fibrillation in Alzheimer's disease.
    Jebarupa B; Muralidharan M; Arun A; Mandal AK; Mitra G
    Biophys Chem; 2018 Oct; 241():27-37. PubMed ID: 30081240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Understanding molecular features of aggregation-resistant tau conformer using oxidized monomer.
    Jebarupa B; Mathew B; Srinivasu BY; Sasikumaran A; Joseph S; Mandal AK; Thomas T; Mitra G
    Biochim Biophys Acta Gen Subj; 2019 Jun; 1863(6):993-1005. PubMed ID: 30853336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resonance Raman spectroscopic measurements delineate the structural changes that occur during tau fibril formation.
    Ramachandran G; Milán-Garcés EA; Udgaonkar JB; Puranik M
    Biochemistry; 2014 Oct; 53(41):6550-65. PubMed ID: 25284680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The natively unfolded character of tau and its aggregation to Alzheimer-like paired helical filaments.
    Jeganathan S; von Bergen M; Mandelkow EM; Mandelkow E
    Biochemistry; 2008 Oct; 47(40):10526-39. PubMed ID: 18783251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can any "non-specific charge modification within microtubule binding domains of Tau" be a prerequisite of the protein amyloid aggregation? An in vitro study on the 1N4R isoform.
    Jangholi A; Ashrafi-Kooshk MR; Arab SS; Karima S; Poorebrahim M; Ghadami SA; Moosavi-Movahedi AA; Khodarahmi R
    Int J Biol Macromol; 2018 Apr; 109():188-204. PubMed ID: 29248553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of the Hereditary P301L Mutation on the Correlated Conformational Dynamics of Human Tau Protein Revealed by the Paramagnetic Relaxation Enhancement NMR Experiments.
    Kawasaki R; Tate SI
    Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32486218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The structure and phase of tau: from monomer to amyloid filament.
    Zeng Y; Yang J; Zhang B; Gao M; Su Z; Huang Y
    Cell Mol Life Sci; 2021 Mar; 78(5):1873-1886. PubMed ID: 33078207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acetylation Disfavors Tau Phase Separation.
    Ferreon JC; Jain A; Choi KJ; Tsoi PS; MacKenzie KR; Jung SY; Ferreon AC
    Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29734651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amyloidogenesis of Tau protein.
    Nizynski B; Dzwolak W; Nieznanski K
    Protein Sci; 2017 Nov; 26(11):2126-2150. PubMed ID: 28833749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperphosphorylation of intrinsically disordered tau protein induces an amyloidogenic shift in its conformational ensemble.
    Zhu S; Shala A; Bezginov A; Sljoka A; Audette G; Wilson DJ
    PLoS One; 2015; 10(3):e0120416. PubMed ID: 25767879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A functional role for intrinsic disorder in the tau-tubulin complex.
    Melo AM; Coraor J; Alpha-Cobb G; Elbaum-Garfinkle S; Nath A; Rhoades E
    Proc Natl Acad Sci U S A; 2016 Dec; 113(50):14336-14341. PubMed ID: 27911791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipid membrane templated misfolding and self-assembly of intrinsically disordered tau protein.
    Majewski J; Jones EM; Vander Zanden CM; Biernat J; Mandelkow E; Chi EY
    Sci Rep; 2020 Aug; 10(1):13324. PubMed ID: 32770092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural impact of heparin binding to full-length Tau as studied by NMR spectroscopy.
    Sibille N; Sillen A; Leroy A; Wieruszeski JM; Mulloy B; Landrieu I; Lippens G
    Biochemistry; 2006 Oct; 45(41):12560-72. PubMed ID: 17029411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conformational transition state is responsible for assembly of microtubule-binding domain of tau protein.
    Hiraoka S; Yao TM; Minoura K; Tomoo K; Sumida M; Taniguchi T; Ishida T
    Biochem Biophys Res Commun; 2004 Mar; 315(3):659-63. PubMed ID: 14975751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural characterization by nuclear magnetic resonance of the impact of phosphorylation in the proline-rich region of the disordered Tau protein.
    Sibille N; Huvent I; Fauquant C; Verdegem D; Amniai L; Leroy A; Wieruszeski JM; Lippens G; Landrieu I
    Proteins; 2012 Feb; 80(2):454-62. PubMed ID: 22072628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross-Linking Mass Spectrometry Analysis of Metastable Compact Structures in Intrinsically Disordered Proteins.
    Chen D; Joachimiak LA
    Methods Mol Biol; 2023; 2551():189-201. PubMed ID: 36310204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure and Functions of Microtubule Associated Proteins Tau and MAP2c: Similarities and Differences.
    Melková K; Zapletal V; Narasimhan S; Jansen S; Hritz J; Škrabana R; Zweckstetter M; Ringkjøbing Jensen M; Blackledge M; Žídek L
    Biomolecules; 2019 Mar; 9(3):. PubMed ID: 30884818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insights into the Molecular Mechanisms of Alzheimer's and Parkinson's Diseases with Molecular Simulations: Understanding the Roles of Artificial and Pathological Missense Mutations in Intrinsically Disordered Proteins Related to Pathology.
    Coskuner-Weber O; Uversky VN
    Int J Mol Sci; 2018 Jan; 19(2):. PubMed ID: 29364151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Secondary structures transition of tau protein with intrinsically disordered proteins specific force field.
    Dan A; Chen HF
    Chem Biol Drug Des; 2019 Mar; 93(3):242-253. PubMed ID: 30259679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.